Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001824293-24-000098
Filing Date
2024-08-02
Accepted
2024-08-02 17:19:36
Documents
4
Period of Report
2024-08-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2024proxystatement.htm DEF 14A 663003
2 GRAPHIC image_0.jpg GRAPHIC 24263
3 GRAPHIC pcpg1.jpg GRAPHIC 129765
4 GRAPHIC pcpg2.jpg GRAPHIC 113285
  Complete submission text file 0001824293-24-000098.txt   1032708
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40034 | Film No.: 241172236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)